Literature DB >> 33925849

Current Perspective of Hydrogen Sulfide as a Novel Gaseous Modulator of Oxidative Stress in Glaucoma.

Yuan Feng1, Verena Prokosch1, Hanhan Liu1.   

Abstract

Glaucoma is a group of diseases characterized by the progressive loss of retinal ganglion cells and their axons. Elevated intraocular pressure (IOP) is the main clinical manifestation of glaucoma. Despite being in the focus of the studies for decades, the characteristic and the exact pathology of neurodegeneration in glaucoma remains unclear. Oxidative stress is believed to be one of the main risk factors in neurodegeneration, especially its damage to the retinal ganglion cells. Hydrogen sulfide (H2S), the recently recognized gas signaling molecule, plays a pivotal role in the nervous system, vascular system, and immune system. It has also shown properties in regulating oxidative stress through different pathways in vivo. In this review, we summarize the distribution and the properties of H2S within the eye with an emphasis on its role in modulating oxidative stress in glaucoma.

Entities:  

Keywords:  glaucoma; hydrogen sulfide; neurodegeneration; oxidative stress

Year:  2021        PMID: 33925849     DOI: 10.3390/antiox10050671

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  122 in total

1.  Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Authors:  Latha Devi; Badanavalu M Prabhu; Domenico F Galati; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

2.  Hydrogen Sulfide Maintains Mitochondrial DNA Replication via Demethylation of TFAM.

Authors:  Shuangshuang Li; Guangdong Yang
Journal:  Antioxid Redox Signal       Date:  2015-05-14       Impact factor: 8.401

Review 3.  Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

Review 4.  Mammalian iron-sulphur proteins: novel insights into biogenesis and function.

Authors:  Tracey A Rouault
Journal:  Nat Rev Mol Cell Biol       Date:  2014-11-26       Impact factor: 94.444

5.  Slow regulated release of H2S inhibits oxidative stress induced cell death by influencing certain key signaling molecules.

Authors:  Aman Shah Abdul Majid; Amin Malik Shah Abdul Majid; Zheng Qin Yin; Dan Ji
Journal:  Neurochem Res       Date:  2013-04-14       Impact factor: 3.996

Review 6.  Signaling molecules: hydrogen sulfide and polysulfide.

Authors:  Hideo Kimura
Journal:  Antioxid Redox Signal       Date:  2014-06-25       Impact factor: 8.401

7.  Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.

Authors:  Hanhan Liu; Fabian Anders; Solon Thanos; Carolina Mann; Aiwei Liu; Franz H Grus; Norbert Pfeiffer; Verena Prokosch-Willing
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

8.  Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open angle glaucoma and normal pressure glaucoma.

Authors:  P Hamard; H Hamard; J Dufaux; S Quesnot
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

9.  [Morphological and Quantitative Changes in Retinal and Optic Nerve Vessels in Experimental Glaucoma Model with Elevated IOP for 7 Weeks].

Authors:  Carolina Mann; Fabian Anders; Hanhan Liu; Katrin Brockhaus; Aiwei Liu; Franz H Grus; Norbert Pfeiffer; Solon Thanos; Verena Prokosch
Journal:  Klin Monbl Augenheilkd       Date:  2018-03-28       Impact factor: 0.700

Review 10.  Iron Homeostasis in Health and Disease.

Authors:  Raffaella Gozzelino; Paolo Arosio
Journal:  Int J Mol Sci       Date:  2016-01-20       Impact factor: 5.923

View more
  1 in total

Review 1.  Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms.

Authors:  Colleen M McDowell; Krishnakumar Kizhatil; Michael H Elliott; Darryl R Overby; Joseph van Batenburg-Sherwood; J Cameron Millar; Markus H Kuehn; Gulab Zode; Ted S Acott; Michael G Anderson; Sanjoy K Bhattacharya; Jacques A Bertrand; Terete Borras; Diane E Bovenkamp; Lin Cheng; John Danias; Michael Lucio De Ieso; Yiqin Du; Jennifer A Faralli; Rudolf Fuchshofer; Preethi S Ganapathy; Haiyan Gong; Samuel Herberg; Humberto Hernandez; Peter Humphries; Simon W M John; Paul L Kaufman; Kate E Keller; Mary J Kelley; Ruth A Kelly; David Krizaj; Ajay Kumar; Brian C Leonard; Raquel L Lieberman; Paloma Liton; Yutao Liu; Katy C Liu; Navita N Lopez; Weiming Mao; Timur Mavlyutov; Fiona McDonnell; Gillian J McLellan; Philip Mzyk; Andrews Nartey; Louis R Pasquale; Gaurang C Patel; Padmanabhan P Pattabiraman; Donna M Peters; Vijaykrishna Raghunathan; Ponugoti Vasantha Rao; Naga Rayana; Urmimala Raychaudhuri; Ester Reina-Torres; Ruiyi Ren; Douglas Rhee; Uttio Roy Chowdhury; John R Samples; E Griffen Samples; Najam Sharif; Joel S Schuman; Val C Sheffield; Cooper H Stevenson; Avinash Soundararajan; Preeti Subramanian; Chenna Kesavulu Sugali; Yang Sun; Carol B Toris; Karen Y Torrejon; Amir Vahabikashi; Janice A Vranka; Ting Wang; Colin E Willoughby; Chen Xin; Hongmin Yun; Hao F Zhang; Michael P Fautsch; Ernst R Tamm; Abbot F Clark; C Ross Ethier; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.